CARLSBAD, Calif., July 7, 2015 /PRNewswire/ -- Essentialis, a venture-backed company focused on the development of KATP channel agonists for the treatment of orphan neurobehavioral and metabolic diseases, today announced that Dr. Neil M. Cowen, President and CSO, will present a corporate update at the Cantor Fitzgerald Inaugural Healthcare Conference.
Cantor Fitzgerald Healthcare Conference
Date: Wednesday, July 8, 2015
Time: 8:00 AM Eastern Time
Location: New York City
About Essentialis, Inc.
Essentialis is a Carlsbad-based, orphan drug focused, pharmaceutical company focused on the development of breakthrough medicines targeted to the ATP-sensitive potassium channel, a metabolically regulated membrane protein whose modulation has the potential to treat and prevent a wide range of metabolic, CNS and cardiovascular diseases.
For more information visit. http://essentialistherapeutics.com/.